Work

Combination of Bendamustine, Lenalidomide, and Dexamethasone In Patients with Refractory or Relapsed Multiple Myeloma Is Safe and Highly Effective: Results of a Phase I Clinical Trial

Year: 2010

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v116.21.989.989

Authors: Suzanne Lentzsch, Amy O'Sullivan, Ryan Kennedy, Navkiranjit Gill, Carrie Andreas, Diane Gardner, Silvana Lalo, Steve Burt, Robert L. Redner, Robert Volkin, David Roodman, Markus Y Mapara, Frank Viverette, Mounzer Agha, Jeffrey A. Zonder

Institutions: University of Pittsburgh, UPMC Hillman Cancer Center, The Barbara Ann Karmanos Cancer Institute, UPMC Health System, University of Pittsburgh Medical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2557591402

FWCI: 0.799

Cites:

Cited by: 4

Related to: 10